1. Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer. Issue 7 (July 2021) Authors: Seligson, John M.; Patron, Alexandra M.; Berger, Michael J.; Harvey, R. Donald; Seligson, Nathan D. Journal: Annals of pharmacotherapy Issue: Volume 55:Issue 7(2021) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗